The company's NeuroShield device is a chitosan-based membrane designed to repair peripheral nerve injuries without gaps or with gap closure achieved by extremity flexion. It provides non-constricting protection for the nervous system, shielding nerves from additional harm and facilitating accelerated recovery from nerve damage. Additionally, Monarch Bioimplants, a subsidiary of NeuroShield, has engineered a chitosan-based medical device that reduces the occurrence of impotence following a radical prostatectomy, a surgery for cancer patients to remove the prostate.